| 000 | 01828 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250517223506.0 | ||
| 264 | 0 | _c20190610 | |
| 008 | 201906s 0 0 eng d | ||
| 022 | _a1533-4023 | ||
| 024 | 7 |
_a10.1097/FJC.0000000000000604 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJanssen, Paul M L | |
| 245 | 0 | 0 |
_aHuman Myocardium Has a Robust α1A-Subtype Adrenergic Receptor Inotropic Response. _h[electronic resource] |
| 260 |
_bJournal of cardiovascular pharmacology _c09 2018 |
||
| 300 |
_a136-142 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. | ||
| 650 | 0 | 4 |
_aAdrenergic alpha-1 Receptor Agonists _xpharmacology |
| 650 | 0 | 4 |
_aAdrenergic beta-Agonists _xpharmacology |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aCardiotonic Agents _xpharmacology |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHeart Failure _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImidazoles _xpharmacology |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 |
_aIsoproterenol _xpharmacology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMyocardial Contraction _xdrug effects |
| 650 | 0 | 4 |
_aMyocardium _xmetabolism |
| 650 | 0 | 4 |
_aReceptors, Adrenergic, alpha-1 _xdrug effects |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 |
_aTetrahydronaphthalenes _xpharmacology |
| 650 | 0 | 4 |
_aVentricular Function, Right _xdrug effects |
| 700 | 1 | _aCanan, Benjamin D | |
| 700 | 1 | _aKilic, Ahmet | |
| 700 | 1 | _aWhitson, Bryan A | |
| 700 | 1 | _aBaker, Anthony J | |
| 773 | 0 |
_tJournal of cardiovascular pharmacology _gvol. 72 _gno. 3 _gp. 136-142 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/FJC.0000000000000604 _zAvailable from publisher's website |
| 999 |
_c28551150 _d28551150 |
||